<DOC>
	<DOCNO>NCT02307201</DOCNO>
	<brief_summary>There evidence patient receive magnesium sulfate birth require maintain drug 24 hour . Therefore investigator randomize clinical study patient severe preeclampsia treated impregnation magnesium sulphate least eight hour receive drug birth . If patient agree sign consent randomize : 1-receive sulfate 24 hour postpartum usual , 2- receiving postpartum magnesium sulfate anticonvulsant drug . This study conduct 12 maternity latin america .</brief_summary>
	<brief_title>Magnesium Sulfate During Postpartum Women With Severe Preeclampsia</brief_title>
	<detailed_description>The final treatment know pre-eclampsia eclampsia termination pregnancy . However prevent eclampsia patient severe pre-eclampsia demonstrated effectiveness magnesium sulfate . There multiple study prove effectiveness magnesium sulfate prevent eclampsia patient severe disorder blood pressure pregnancy . These study use drug birth continue birth . Therefore investigator conclude whether administration pregnancy sufficient prevent seizure . If cure definitive treatment pre-eclampsia interruption , seem necessary justify administration drug anti-eclampsia birth . Obvious post delivery management magnesium sulfate arise large number postpartum eclampsia report many study . It unknown whether administration magnesium sulfate minimum period delivery , require even keep drug post partum . In addition magnesium sulfate postpartum , necessary maintain urinary catheter monitor removal magnesium sulfate ; usual maintain patient almost rest monitoring sulfate diuresis , prevents proper relationship mother babe even prevents breastfeed period also know increase risk secondary thromboembolism due prolong rest postpartum / caesarean section.Thus , maintain magnesium sulfate 24 hour carry high cost , great vigilance risk , without know real effect . A randomized clinical study conduct Belfort colleague publish January 2003 , magnesium sulphate compare nimodipine prevent eclampsia woman severe pre-eclampsia , show interesting outcome . Such research analyze 819 randomized patient nimodipine group 831 magnesium sulfate group . Magnesium sulphate well Nimodipine prevent eclampsia . Interestingly , great effectiveness sulfate appear prevent eclampsia postpartum ( 9 vs 0 ) obviously use termination pregnancy , however difference compare nimodipine eclampsia birth ( 12 vs 7 ) . There two possible reason non-appearance postpartum eclampsia : 1- maintain postpartum magnesium sulfate , 2- dose 12-13 gram birth disruption sufficient prevent eclampsia . The MAGPIE study randomize 1335 postpartum patient ( unused sulphate delivery ) use magnesium sulfate postpartum / cesarean ( 696 woman ) placebo postpartum / cesarean ( 639 woman ) , find significant difference amount eclampsia . Thus , use magnesium sulfate first time postpartum well use placebo . If investigator combine finding eclampsia postpartum Belfort study MAGPIE study logical think success Belfort study postpartum use magnesium sulfate post delivery due termination pregnancy postpartum eclampsia nimodipine group . If investigator consider unjustified use magnesium sulfate postpartum , maintain least 8 hour delivery , investigator decide make non-inferiority randomize study.The investigator assume use use magnesium sulfate postpartum prevents similar amount postpartum eclampsia , pregnancy use ( impregnation least 8 hour birth ) . For reason investigator propose follow : A randomized trial necessary patient receive magnesium sulfate least 8 hour birth ( involve impregnation maintenance 8 hour ) randomize two group study : 1- Continue magnesium sulfate 24 hour 2-not use magnesium sulfate anticonvulsant drug post delivery . This study plan 12 maternity latin america</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>Severe preeclampsia severe preeclampsia aggregate chronic hypertension &gt; 24 week gestation treat 46 gram magnesium sulfate impregnation minimum 8 hour continuous magnesium sulfate delivery The study begin terminate pregnancy HELLP syndrome Eclampsia Renal insufficiency Diabetes mellitus Disease collagen Heart disease</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>